[HTML][HTML] Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity

P Mehta, IO Rosas, M Singer - Intensive Care Medicine, 2022 - Springer
Immunomodulation and immunity from vaccination and natural infection have reduced
mortality from coronavirus disease 2019 (COVID-19). However, there are ongoing concerns …

Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity

P Mehta, IO Rosas, M Singer - Intensive Care Medicine, 2022 - discovery.ucl.ac.uk
Immunomodulation and immunity from vaccination and natural infection have reduced
mortality from coronavirus disease 2019 (COVID-19). However, there are ongoing concerns …

Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity

P Mehta, IO Rosas, M Singer - Intensive Care Medicine, 2022 - search.proquest.com
Immunomodulation and immunity from vaccination and natural infection have reduced
mortality from coronavirus disease 2019 (COVID-19). However, there are ongoing concerns …

[引用][C] Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity

P Mehta, IO Rosas, M Singer - Intensive Care Medicine, 2022 - cir.nii.ac.jp
Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease
entity | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

[HTML][HTML] Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity

P Mehta, IO Rosas, M Singer - Intensive Care Medicine, 2022 - ncbi.nlm.nih.gov
Immunomodulation and immunity from vaccination and natural infection have reduced
mortality from coronavirus disease 2019 (COVID-19). However, there are ongoing concerns …

[引用][C] Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity

P Mehta, IO Rosas, M Singer - Intensive care medicine, 2022 - pubmed.ncbi.nlm.nih.gov
Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease
entity Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory …

[PDF][PDF] Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity

P Mehta, IO Rosas, M Singer - Intensive Care Med, 2022 - researchgate.net
Immunomodulation and immunity from vaccination and natural infection have reduced
mortality from coronavirus disease 2019 (COVID-19). However, there are ongoing concerns …

Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity.

P Mehta, IO Rosas, M Singer - Intensive Care Medicine, 2022 - europepmc.org
Immunomodulation and immunity from vaccination and natural infection have reduced
mortality from coronavirus disease 2019 (COVID-19). However, there are ongoing concerns …

[PDF][PDF] Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity

P Mehta, IO Rosas, M Singer - 2022 - researchgate.net
Immunomodulation and immunity from vaccination and natural infection have reduced
mortality from coronavirus disease 2019 (COVID-19). However, there are ongoing concerns …

[引用][C] Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity.

P Mehta, IO Rosas, M Singer - Intensive Care Medicine, 2022 - europepmc.org
Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease
entity. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …